☰

Andrew P. Bradford - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Zhao L, Iwanaga R, Bradford AP, Kurayoshi K, Araki K, Ohtani K. Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression. Biology. 12. PMID 38132337 DOI: 10.3390/biology12121511  0.356
2023 Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H, Fikriyanti M, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K. Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool. Genes. 14. PMID 36833320 DOI: 10.3390/genes14020393  0.361
2020 Jones K, Ryan S, Carlson NE, Chosich J, Bradford AP, Santoro N, Polotsky AJ. Aromatase Inhibition Ameliorates Decreased LH Output Found in Obese Women. Reproductive Sciences (Thousand Oaks, Calif.). PMID 32046430 DOI: 10.1007/S43032-019-00105-5  0.315
2019 Adams CL, Dimitrova I, Post MD, Gibson L, Spillman MA, Behbakht K, Bradford AP. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma. Experimental and Molecular Pathology. 104284. PMID 31301306 DOI: 10.1016/J.Yexmp.2019.104284  0.351
2019 Bauer JL, Kuhn K, Bradford AP, Al-Safi ZA, Harris MA, Eckel RH, Robledo CY, Malkhasyan A, Johnson J, Gee NR, Polotsky AJ. Reduction in FSH Throughout the Menstrual Cycle After Omega-3 Fatty Acid Supplementation in Young Normal Weight but not Obese Women. Reproductive Sciences (Thousand Oaks, Calif.). 1933719119828099. PMID 30773100 DOI: 10.1177/1933719119828099  0.315
2018 Komori H, Goto Y, Kurayoshi K, Ozono E, Iwanaga R, Bradford AP, Araki K, Ohtani K. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes. Scientific Reports. 8: 8438. PMID 29855511 DOI: 10.1038/S41598-018-26860-0  0.421
2018 Kuhn K, Bradford A, Polotsky A. Stimulation with recombinant FSH acutely and significantly increases inhibin B and estradiol in women after GnRH antagonist treatment: a model to study FSH regulation of ovarian function Fertility and Sterility. 110: e251. DOI: 10.1016/J.Fertnstert.2018.07.717  0.303
2016 Kurayoshi K, Shiromoto A, Ozono E, Iwanaga R, Bradford AP, Araki K, Ohtani K. Ectopic expression of the CDK inhibitor p21(Cip1) enhances deregulated E2F activity and increases cancer cell-specific cytotoxic gene expression mediated by the ARF tumor suppressor promoter. Biochemical and Biophysical Research Communications. PMID 28042030 DOI: 10.1016/J.Bbrc.2016.12.185  0.471
2016 Kurayoshi K, Okuno J, Ozono E, Iwanaga R, Bradford AP, Kugawa K, Araki K, Ohtani K. The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity. Biochemical and Biophysical Research Communications. PMID 27888102 DOI: 10.1016/J.Bbrc.2016.11.111  0.435
2016 Kuokkanen S, Polotsky AJ, Chosich J, Bradford AP, Jasinska A, Phang T, Santoro N, Appt SE. Corpus luteum as a novel target of weight changes that contribute to impaired female reproductive physiology and function. Systems Biology in Reproductive Medicine. 1-16. PMID 27187064 DOI: 10.3109/19396368.2016.1173743  0.322
2015 Bradford AP, Jones K, Kechris K, Chosich J, Montague M, Warren WC, May MC, Al-Safi Z, Kuokkanen S, Appt SE, Polotsky AJ. Joint MiRNA/mRNA Expression Profiling Reveals Changes Consistent with Development of Dysfunctional Corpus Luteum after Weight Gain. Plos One. 10: e0135163. PMID 26258540 DOI: 10.1371/Journal.Pone.0135163  0.324
2015 Kitamura H, Ozono E, Iwanaga R, Bradford AP, Okuno J, Shimizu E, Kurayoshi K, Kugawa K, Toh H, Ohtani K. Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. PMID 26201719 DOI: 10.1111/Gtc.12268  0.397
2015 Merhi Z, Polotsky AJ, Bradford AP, Buyuk E, Chosich J, Phang T, Jindal S, Santoro N. Adiposity Alters Genes Important in Inflammation and Cell Cycle Division in Human Cumulus Granulosa Cell. Reproductive Sciences (Thousand Oaks, Calif.). PMID 25676576 DOI: 10.1177/1933719115572484  0.365
2014 Kurayoshi K, Ozono E, Iwanaga R, Bradford AP, Komori H, Ohtani K. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs. Biochemical and Biophysical Research Communications. 450: 240-6. PMID 24893334 DOI: 10.1016/J.Bbrc.2014.05.102  0.457
2014 Roth LW, Allshouse AA, Bradshaw-Pierce EL, Lesh J, Chosich J, Kohrt W, Bradford AP, Polotsky AJ, Santoro N. Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women. Clinical Endocrinology. 81: 418-25. PMID 24576183 DOI: 10.1111/Cen.12441  0.301
2014 Dai D, Bradford AP, Prossnitz ER. Endometrial cancer: molecular and cellular basis of tumor development, novel biomarkers and therapeutic agents, and innovative research approaches. Obstetrics and Gynecology International. 2014: 710405. PMID 24550988 DOI: 10.1155/2014/710405  0.476
2014 Ross LA, Polotsky AJ, Kucherov A, Bradford AP, Lesh J, Chosich J, Gee N, Santoro N. Profound reduction of ovarian estrogen by aromatase inhibition in obese women. Obesity (Silver Spring, Md.). 22: 1464-9. PMID 24482405 DOI: 10.1002/Oby.20713  0.333
2013 Thorne AM, Jackson TA, Willis VC, Bradford AP. Protein Kinase C α Modulates Estrogen-Receptor-Dependent Transcription and Proliferation in Endometrial Cancer Cells. Obstetrics and Gynecology International. 2013: 537479. PMID 23843797 DOI: 10.1155/2013/537479  0.456
2013 Polotsky A, Liu H, Carlson N, Chosich J, Bradford A, Santoro N. Recovery of luteinizing hormone secretion after aromatase inhibition in obese women Fertility and Sterility. 100: S129. DOI: 10.1016/J.Fertnstert.2013.07.1617  0.311
2012 Iwanaga R, Wang CA, Micalizzi DS, Harrell JC, Jedlicka P, Sartorius CA, Kabos P, Farabaugh SM, Bradford AP, Ford HL. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Research : Bcr. 14: R100. PMID 22765220 DOI: 10.1186/Bcr3219  0.431
2012 Korch C, Spillman MA, Jackson TA, Jacobsen BM, Murphy SK, Lessey BA, Jordan VC, Bradford AP. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecologic Oncology. 127: 241-8. PMID 22710073 DOI: 10.1016/J.Ygyno.2012.06.017  0.376
2011 Dimitrova I, Ramanathan P, Neville M, Bradford A. Analysis of differential diagnostic gene expression profiles in uterine leiomyoma and leiomyosarcoma Gynecologic Oncology. 123: 445. DOI: 10.1016/J.Ygyno.2011.07.080  0.365
2009 Haughian JM, Reno EM, Thorne AM, Bradford AP. Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis. International Journal of Cancer. Journal International Du Cancer. 125: 2556-64. PMID 19672862 DOI: 10.1002/Ijc.24633  0.731
2009 Reno EM, Haughian JM, Jackson TA, Thorne AM, Bradford AP. c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells. Apoptosis : An International Journal On Programmed Cell Death. 14: 809-20. PMID 19424800 DOI: 10.1007/S10495-009-0354-6  0.738
2009 Haughian JM, Bradford AP. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells. Journal of Cellular Physiology. 220: 112-8. PMID 19235902 DOI: 10.1002/Jcp.21741  0.734
2008 Reno EM, Haughian JM, Dimitrova IK, Jackson TA, Shroyer KR, Bradford AP. Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors. Human Pathology. 39: 21-9. PMID 17959229 DOI: 10.1016/J.Humpath.2007.05.023  0.739
2007 Gutierrez-Hartmann A, Duval DL, Bradford AP. ETS transcription factors in endocrine systems. Trends in Endocrinology and Metabolism: Tem. 18: 150-8. PMID 17387021 DOI: 10.1016/J.Tem.2007.03.002  0.352
2006 Haughian JM, Jackson TA, Koterwas DM, Bradford AP. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta. Endocrine-Related Cancer. 13: 1251-67. PMID 17158769 DOI: 10.1677/Erc.1.01278  0.74
2006 Siriwardana G, Bradford A, Coy D, Zeitler P. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Molecular Endocrinology (Baltimore, Md.). 20: 2010-9. PMID 16613992 DOI: 10.1210/Me.2005-0001  0.478
2006 Jackson TA, Koterwas DM, Bradford AP. Differential regulation of cell growth and gene expression by FGF-2 and FGF-4 in pituitary lactotroph GH4 cells. Molecular and Cellular Endocrinology. 247: 183-91. PMID 16469431 DOI: 10.1016/J.Mce.2006.01.002  0.415
2004 Farrow KN, Bradford AP, Tentler JJ, Gutierrez-Hartmann A. Structural and functional analysis of the differential effects of c-Jun and v-Jun on prolactin gene expression. Molecular Endocrinology (Baltimore, Md.). 18: 2479-90. PMID 15231872 DOI: 10.1210/Me.2004-0113  0.347
2003 Jackson TA, Koterwas DM, Morgan MA, Bradford AP. Fibroblast growth factors regulate prolactin transcription via an atypical Rac-dependent signaling pathway. Molecular Endocrinology (Baltimore, Md.). 17: 1921-30. PMID 12843210 DOI: 10.1210/Me.2003-0167  0.455
2003 Tentler JJ, Bradford AP, Schweppe RE, Gutierrez-Hartmann A. Selective repression of rat prolactin gene by stable expression of dominant-negative Ets in GH4 pituitary cells. Endocrine. 20: 3-12. PMID 12668863 DOI: 10.1385/Endo:20:1-2:3  0.379
2001 Jackson TA, Schweppe RE, Koterwas DM, Bradford AP. Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta. Molecular Endocrinology (Baltimore, Md.). 15: 1517-28. PMID 11518800 DOI: 10.1210/Mend.15.9.0683  0.426
1997 Schweppe RE, Frazer-Abel AA, Gutierrez-Hartmann A, Bradford AP. Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene. The Journal of Biological Chemistry. 272: 30852-9. PMID 9388230 DOI: 10.1074/Jbc.272.49.30852  0.374
1997 Wasylyk C, Bradford AP, Gutierrez-Hartmann A, Wasylyk B. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene. 14: 899-913. PMID 9050989 DOI: 10.1038/Sj.Onc.1200914  0.331
1997 Bradford AP, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A. Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression. Molecular and Cellular Biology. 17: 1065-74. PMID 9032233 DOI: 10.1128/Mcb.17.3.1065  0.304
1996 Bradford AP, Conrad KE, Tran PH, Ostrowski MC, Gutierrez-Hartmann A. GHF-1/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element. The Journal of Biological Chemistry. 271: 24639-48. PMID 8798730 DOI: 10.1074/Jbc.271.40.24639  0.309
1995 Bradford AP, Conrad KE, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A. Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain. Molecular and Cellular Biology. 15: 2849-57. PMID 7739565 DOI: 10.1128/Mcb.15.5.2849  0.349
Show low-probability matches.